enterprise value $100m - lani superior tamiflu, page-8

Quoting dday1:
Current BTA had nothing to do with Relenza licencing. In the industry 7%-10% is not a bad deal anywway for his type of thing.

For a minute I almost believe it. Then I remembered the guy had put every spare $ into Biota and is suffering a paper loss - therefore trying to ramp up the shares or perhaps posting as a stooge for management.

The current management refused the $100m settlement offer and the sold out shareholders for $20m purportedly to normalised relationship.
Who is that a broken record player that keep posting the current BTA management has nothing to do with the licensing. LOL